maxresorb®
BRIEF PROFILE |
 |
reg.: n/a register now |
||||||
 |
||||||||
| 01 | application | oral hard tissue substitute, bone | ||||||
| 02 | specific | synthetic bone | ||||||
| 03 | company | botiss biomaterials GmbH | ||||||
| 04 | illustration |  |
||||||
| 05 | material | 60% hydoxyapatite, 40% beta-tricalcium phosphate | ||||||
| 06 | year of introduction | n/a | ||||||
| 07 | approvals | X | CE-Label | n/a | FDA-approval | |||
| n/a | double-blind test | n/a | prospective randomized controlled clinical study | |||||
| n/a | other | |||||||
| 08 | last update | 2017-02-21 | ||||||
|
this page is not approved by the provider |
||||||||
| Information given here are checked thoroughly by “Implant-Register”. However we can not guarantee for any material or properties. Ask the manufacturer for such questions and give us the information to improve the Register. | ||||||||